These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 30287142)

  • 61. Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma.
    Xue X; Gao W; Sun B; Xu Y; Han B; Wang F; Zhang Y; Sun J; Wei J; Lu Z; Zhu Y; Sato Y; Sekido Y; Miao Y; Kondo Y
    Oncogene; 2013 Mar; 32(13):1724-34. PubMed ID: 22614011
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Bclaf1 promotes angiogenesis by regulating HIF-1α transcription in hepatocellular carcinoma.
    Wen Y; Zhou X; Lu M; He M; Tian Y; Liu L; Wang M; Tan W; Deng Y; Yang X; Mayer MP; Zou F; Chen X
    Oncogene; 2019 Mar; 38(11):1845-1859. PubMed ID: 30367150
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Upregulation of CCL20 and recruitment of CCR6+ gastric infiltrating lymphocytes in Helicobacter pylori gastritis.
    Wu YY; Tsai HF; Lin WC; Hsu PI; Shun CT; Wu MS; Hsu PN
    Infect Immun; 2007 Sep; 75(9):4357-63. PubMed ID: 17562763
    [TBL] [Abstract][Full Text] [Related]  

  • 64. CCR6, the sole receptor for the chemokine CCL20, promotes spontaneous intestinal tumorigenesis.
    Nandi B; Pai C; Huang Q; Prabhala RH; Munshi NC; Gold JS
    PLoS One; 2014; 9(5):e97566. PubMed ID: 24866282
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The relationship between CCR6 and its binding partners: does the CCR6-CCL20 axis have to be extended?
    Lee AY; Phan TK; Hulett MD; Körner H
    Cytokine; 2015 Mar; 72(1):97-101. PubMed ID: 25585877
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Chemokine receptor CCR6-dependent accumulation of γδ T cells in injured liver restricts hepatic inflammation and fibrosis.
    Hammerich L; Bangen JM; Govaere O; Zimmermann HW; Gassler N; Huss S; Liedtke C; Prinz I; Lira SA; Luedde T; Roskams T; Trautwein C; Heymann F; Tacke F
    Hepatology; 2014 Feb; 59(2):630-42. PubMed ID: 23959575
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The necroptosis related gene LGALS3 can be used as a biomarker for the adverse progression from chronic HBV infection to HCC.
    Dong J; Zhang R; Xia Y; Jiang X; Zhou K; Li J; Guo M; Cao X; Zhang S
    Front Immunol; 2023; 14():1142319. PubMed ID: 37180150
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues.
    Xuan SY; Xin YN; Chen H; Shi GJ; Guan HS; Li Y
    World J Gastroenterol; 2007 Mar; 13(12):1870-4. PubMed ID: 17465484
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Lipid droplet accumulation mediates macrophage survival and Treg recruitment via the CCL20/CCR6 axis in human hepatocellular carcinoma.
    Wang Y; Chen W; Qiao S; Zou H; Yu XJ; Yang Y; Li Z; Wang J; Chen MS; Xu J; Zheng L
    Cell Mol Immunol; 2024 Oct; 21(10):1120-1130. PubMed ID: 38942796
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Promotion of Cancer Stem-Like Cell Properties in Hepatitis C Virus-Infected Hepatocytes.
    Kwon YC; Bose SK; Steele R; Meyer K; Di Bisceglie AM; Ray RB; Ray R
    J Virol; 2015 Nov; 89(22):11549-56. PubMed ID: 26355082
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model.
    Hirota K; Yoshitomi H; Hashimoto M; Maeda S; Teradaira S; Sugimoto N; Yamaguchi T; Nomura T; Ito H; Nakamura T; Sakaguchi N; Sakaguchi S
    J Exp Med; 2007 Nov; 204(12):2803-12. PubMed ID: 18025126
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Regulation of CD4⁺FOXP3⁺ T cells by CCL20/CCR6 axis in early unexplained recurrent miscarriage patients.
    Zhang XX; Kang XM; Zhao AM
    Genet Mol Res; 2015 Aug; 14(3):9145-54. PubMed ID: 26345847
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Fatty acid binding protein 5 promotes tumor angiogenesis and activates the IL6/STAT3/VEGFA pathway in hepatocellular carcinoma.
    Pan L; Xiao H; Liao R; Chen Q; Peng C; Zhang Y; Mu T; Wu Z
    Biomed Pharmacother; 2018 Oct; 106():68-76. PubMed ID: 29957468
    [TBL] [Abstract][Full Text] [Related]  

  • 74. CCL20 blockade increases the severity of nephrotoxic folic acid-induced acute kidney injury.
    González-Guerrero C; Morgado-Pascual JL; Cannata-Ortiz P; Ramos-Barron MA; Gómez-Alamillo C; Arias M; Mezzano S; Egido J; Ruiz-Ortega M; Ortiz A; Ramos AM
    J Pathol; 2018 Oct; 246(2):191-204. PubMed ID: 29984403
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma.
    Sukowati CH; El-Khobar KE; Ie SI; Anfuso B; Muljono DH; Tiribelli C
    World J Gastroenterol; 2016 Jan; 22(4):1497-512. PubMed ID: 26819517
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Expression of pro- and anti-inflammatory cytokines in relation to apoptotic genes in Egyptian liver disease patients associated with HCV-genotype-4.
    Zekri AR; Bahnassy AA; Abdel-Wahab SA; Khafagy MM; Loutfy SA; Radwan H; Shaarawy SM
    J Gastroenterol Hepatol; 2009 Mar; 24(3):416-28. PubMed ID: 19054267
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Purinoceptor expression in hepatocellular virus (HCV)-induced and non-HCV hepatocellular carcinoma: an insight into the proviral role of the P2X4 receptor.
    Khalid M; Manzoor S; Ahmad H; Asif A; Bangash TA; Latif A; Jaleel S
    Mol Biol Rep; 2018 Dec; 45(6):2625-2630. PubMed ID: 30343397
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The CCR2
    Bartneck M; Schrammen PL; Möckel D; Govaere O; Liepelt A; Krenkel O; Ergen C; McCain MV; Eulberg D; Luedde T; Trautwein C; Kiessling F; Reeves H; Lammers T; Tacke F
    Cell Mol Gastroenterol Hepatol; 2019; 7(2):371-390. PubMed ID: 30704985
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The role of chemokine CC ligand 20 in patients with liver cirrhosis and hepatocellular carcinoma.
    Soliman HH; Nagy H; Kotb N; Alm El-Din MA
    Int J Biol Markers; 2012 Jul; 27(2):e125-31. PubMed ID: 22388957
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Suppression of androgen receptor signaling induces prostate cancer migration via activation of the CCL20-CCR6 axis.
    Kano H; Izumi K; Hiratsuka K; Toriumi R; Nakagawa R; Aoyama S; Kamijima T; Shimada T; Naito R; Kadomoto S; Iwamoto H; Yaegashi H; Kawaguchi S; Nohara T; Shigehara K; Kadono Y; Saito Y; Nakagawa-Goto K; Yoshioka K; Nakata H; Lin WJ; Mizokami A
    Cancer Sci; 2023 Apr; 114(4):1479-1490. PubMed ID: 36479732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.